NxStage
NxStage Medical, Inc. (acquired by Fresenius Medical Care in 2019) was a medical device company primarily known for its innovative products in the field of kidney disease and dialysis. Its most recognized product was the NxStage System One, a portable hemodialysis system designed for home hemodialysis and point-of-care use.
The NxStage System One offered patients greater flexibility and control over their dialysis treatments. Unlike traditional in-center hemodialysis, which requires patients to visit a dialysis center multiple times per week, the NxStage System One allowed patients to perform dialysis in the comfort of their own homes, often more frequently and for shorter durations. This was intended to improve patient outcomes and quality of life.
Key features and benefits associated with the NxStage System One included:
- Portability: The system was designed to be compact and easily transportable, enabling dialysis during travel.
- Simplified Operation: The system aimed to simplify the dialysis process for patients and their care partners.
- Frequent Dialysis: The system supported short daily or nocturnal dialysis, potentially leading to improved clinical outcomes.
- Point-of-Care Applications: In addition to home use, the system was utilized in hospital and clinic settings for acute kidney injury and other indications.
While NxStage Medical, Inc. is no longer an independent entity, the NxStage System One continues to be marketed and supported by Fresenius Medical Care and plays a significant role in expanding access to home hemodialysis and providing more flexible treatment options for patients with kidney failure.